Drugs / DWJ1521
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04827472 | Jan → Jun 2021 | — | Daewoong Pharmaceutical Co. LTD. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DWJ1521 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04827472 ↗ |
| Route | Intravenous | “single intravenous administration of DWJ1521” NCT04827472 ↗ |